ArticleJournal of clinical medicine2023

Predictive Value of Total Metabolic Tumor Burden Prior to Treatment in NSCLC Patients Treated with Immune Checkpoint Inhibition.

Ken Kudura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.